Stoquity Living researchResearch LedgerSlicesMethodologyFor institutionsAbout
Stoquity Research Ledger

Ecolab (ECL)

NYSE: ECL · Specialty Chemicals · Saint Paul, MN

Our rating: Neutral

Neutral reaffirmed at $302.98, moderate conviction, October 30, 2026.

Breaks if: The Neutral view turns Positive if revenue growth reaccelerates above 5% year over year and FCF margin expands above 14% across the next two quarterly filings — that combination would signal the multiple is earning its keep. It turns Cautious if reported revenue growth goes flat or negative in the next quarterly filing, or if free cash flow falls below $1.4B on a trailing-twelve-month basis within the next two prints — either would confirm the current price reflects no plausible near-term trajectory.

Key figures

Market value$82.7B
Revenue, last 12 months$17.4B
Net income, last 12 months$2.1B
Free cash flow, last 12 months$1.8B
Price to earnings39.7×
Free cash flow yield2.2%
Dividend yield1.0%
Operating margin16.7%
Return on equity20.7%
Beta to the S&P 5000.54
Volatility, annualized20.8%

Reported quarters

Quarter endingRevenueYear on yearEarnings per shareFree cash flow
September 30, 2026$4.7B12.7%$1.95$450M
June 30, 2026$4.4B9.7%$1.90$489M
March 31, 2026$4.1B10.0%$1.52$97M
December 31, 2025$4.2B4.8%$1.98$758M
September 30, 2025$4.2B4.2%$2.05$530M
June 30, 2025$4.0B1.0%$1.84$485M
March 31, 2025$3.7B−1.5%$1.41$132M
December 31, 2024$4.0B1.7%$1.66$407M

Three-model forecasts for the next quarter

Written November 21, 2026, before the report. Each settles from the SEC filing.

11 ledger entries and 37 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.